Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Subtle Medical Announces Partnership Expansion With Incepto
Subtle Medical, a healthcare technology company improving the quality and efficiency of medical imaging, announced […]
Adipopharma’s First-in-class Candidate - PATAS - Shows Improvement in Whole-body Insulin Resistance and Associated Comorbidities in Vivo
AdipoPharma, formerly ALMS Therapeutics SAS, a biopharmaceutical company focused on innovative peptide-based approaches to treating […]
Thousands Of Patients To Benefit As NHS Marks 100th Fast-Tracked Cancer Drug
Thousands of people a year with advanced breast cancer will benefit from a life-extending drug […]
Moderna's Omicron-containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared to Currently Authorized Booster
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Fujifilm Europe Launches New Hybrid C-arm and Portable X-ray Device
The FDR CROSS platform provides advanced fluoroscopic and radiographic imaging, powered by Fujifilm’s FDR D-EVO […]
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
Moderna Announces First Participant Dosed in a Phase 1 Trial of Its Nipah Virus mRNA Vaccine, mRNA-1215
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Ai-powered Drug Discovery Company Healx Opens New Labs at Chesterford Research Park
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare […]
Provepharm Receives FDA Marketing Approval in US for BLUDIGO, Its Indigo Carmine Injection Drug Product
Provepharm, a French company specialized in the development of pharmaceutical applications, today announces that it […]
Accelerate Diagnostics Announces Commercialization in Europe of Its Accelerate Arc™ System Having Completed IVDR Registration
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more